

					

						November 5, 2017 - By Linda Rogers
Sio Capital Management Llc decreased its stake in Sanofi Sa (SNY) by 32.84% based on its latest 2017Q2 regulatory filing with the SEC. Sio Capital Management Llc sold 88,800 shares as the company’s stock rose 14.25% with the market. The institutional investor held 181,622 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $8.70 million, down from 270,422 at the end of the previous reported quarter. Sio Capital Management Llc who had been investing in Sanofi Sa for a number of months, seems to be less bullish one the $115.82B market cap company. The stock decreased 1.00% or $0.46 on November 3, reaching $45.74. About 805,447 shares traded. Sanofi SA (ADR) (NYSE:SNY) has risen 26.96% since November 5, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.More notable recent Sanofi SA (ADR) (NYSE:SNY) news were published by: Benzinga.com which released: “Regeneron Pharmaceuticals Gains A Bull Ahead Of Earnings” on November 03, 2017, also Investorplace.com with their article: “3 Stocks to Watch on Monday: Tesla Inc (TSLA), Sanofi SA (ADR) (SNY) and …” published on April 03, 2017, Investorplace.com published: “5 Reasons Why Sanofi SA (ADR) (SNY) is a Good Stock to Buy Now” on April 12, 2017. More interesting news about Sanofi SA (ADR) (NYSE:SNY) were released by: Benzinga.com and their article: “The Pullback In Sanofi Is A Buying Opportunity, Says Argus” published on September 01, 2017 as well as Foxbusiness.com‘s news article titled: “ADRs End Mixed; Sanofi Trades Actively” with publication date: October 05, 2017.Among 11 analysts covering Sanofi-aventis Sa (NYSE:SNY), 3 have Buy rating, 0 Sell and 8 Hold. Therefore 27% are positive. Sanofi-aventis Sa had 19 analyst reports since October 15, 2015 according to SRatingsIntel. Morgan Stanley upgraded Sanofi SA (ADR) (NYSE:SNY) on Thursday, October 15 to “Overweight” rating. As per Monday, November 7, the company rating was initiated by Goldman Sachs. The stock has “Buy” rating by Berenberg on Thursday, September 8. The stock of Sanofi SA (ADR) (NYSE:SNY) has “Underperform” rating given on Thursday, December 10 by BNP Paribas. The company was downgraded on Friday, April 7 by HSBC. The firm has “Hold” rating by Cowen & Co given on Tuesday, September 5. The stock of Sanofi SA (ADR) (NYSE:SNY) has “Neutral” rating given on Friday, September 23 by Piper Jaffray. The firm has “Overweight” rating by Barclays Capital given on Thursday, May 12. On Friday, October 13 the stock rating was maintained by Cowen & Co with “Hold”. The stock has “Neutral” rating by JP Morgan on Friday, April 21.Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.
<!-- google_ad_client = "ca-pub-7620071422727774"; /* weeklyregister.com_300x600 */ google_ad_slot = "8032669457/1411802476/1313492366"; google_ad_width = 300; google_ad_height = 600; //-->


